Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The primary aim of this proposal is to conduct a preliminary controlled trial of valproate
and risperidone in children ages 3-7 yr. with bipolar disorders. A secondary aim is to
carefully characterize these subjects using clinical rating scales and develop pilot data on
a very young cohort of children with bipolar disorders that can be used to support an
application to NIMH for a prospective, longitudinal study that will provide important
information about the course, medication response, neurobiology and outcome of these
patients.